Biotech downturn exposes startups to big lease liabilitiesnews2025-05-21T15:00:43+00:00May 21st, 2025|Endpoints News|
Philadelphia doctors treat infant with first custom CRISPR therapy that fixes genetic mutationnews2025-05-15T17:00:12+00:00May 15th, 2025|Endpoints News|
Empower Pharmacy allegedly used low-quality ingredients, skirted rulesnews2025-05-15T13:18:23+00:00May 15th, 2025|Endpoints News|
CRISPR isn’t living up to its potential. Two scientists have a plan to fix thatnews2025-05-08T14:00:20+00:00May 8th, 2025|Endpoints News|
How SalioGen’s attempt to turn ‘jumping genes’ into medicines fell apartnews2025-05-02T11:00:28+00:00May 2nd, 2025|Endpoints News|
US drugmakers seek clinical trials abroad as confidence in FDA waversnews2025-05-01T15:00:08+00:00May 1st, 2025|Endpoints News|
Primate researchers gird for funding cuts as NIH fights court blocknews2025-04-14T15:00:31+00:00April 14th, 2025|Endpoints News|
COVID research cuts target work on antivirals and vaccines to prevent future pandemicsnews2025-03-28T20:06:46+00:00March 28th, 2025|Endpoints News|
Illumina’s CEO evolves strategy with multiomics pushnews2025-03-20T14:30:21+00:00March 20th, 2025|Endpoints News|
How Akido Labs uses AI to run medical visits, from intake to diagnosisnews2025-03-20T10:00:59+00:00March 20th, 2025|Endpoints News|
